APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oxycodone Drug Industry Growth and Trends Forecast to 2032

29 December 2025128 pages

Choose your research edition.

Industry ResearchOxycodone Drug Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Drug Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Oxycodone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Drug Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Oxycodone Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oxycodone Drug include Endone, Endone, Hikma Pharmaceuticals USA, Hikma Pharmaceuticals USA, Janssen Pharmaceuticals(Johnson & Johnson), OxyContin, OxyContin, Oxynorm and Oxynorm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oxycodone Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oxycodone Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxycodone Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxycodone Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oxycodone Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oxycodone Drug Market by Company

Endone

Endone

Hikma Pharmaceuticals USA

Hikma Pharmaceuticals USA

Janssen Pharmaceuticals(Johnson & Johnson)

OxyContin

OxyContin

Oxynorm

Oxynorm

Proladone

Proladone

Purdue Pharma L.P

Purdue Pharma L.P

Sanofi-Aventis S.A.

Sanofi-Aventis S.A.

Sun Pharmaceutical Industries Ltd.

Targin

Targin

Pfizer

Pfizer

Sun Pharmaceutical Industries Ltd.

Janssen Pharmaceuticals(Johnson & Johnson)

Oxycodone Drug Segment by Type

Anesthesia

Anesthesia

Others

Pain Management

Pain Management

Others

Oxycodone Drug Segment by Application

Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers (ASCs)

Hospitals & Clinics

Hospitals & Clinics

Oxycodone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oxycodone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anesthesia Table 2. Major Company of Anesthesia Table 3. Major Company of Others Table 4. Major Company of Pain Management Table 5. Major Company of Pain Management Table 6. Major Company of Others Table 7. Global Oxycodone Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 9. Global Oxycodone Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global Oxycodone Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global Oxycodone Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global Oxycodone Drug Price by Type (2021-2026) & (US$/Unit) Table 13. Global Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 14. Global Oxycodone Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global Oxycodone Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global Oxycodone Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global Oxycodone Drug Price by Type (2027-2032) & (US$/Unit) Table 18. North America Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 19. North America Oxycodone Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 21. Europe Oxycodone Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Oxycodone Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 25. Latin America Oxycodone Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Oxycodone Drug Sales by Type (2021-2026) & (US$ Million) Table 28. Oxycodone Drug Industry Trends Table 29. Oxycodone Drug Industry Drivers Table 30. Oxycodone Drug Industry Opportunities and Challenges Table 31. Oxycodone Drug Industry Restraints Table 32. Global Oxycodone Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Oxycodone Drug Revenue Market Share by Company (2021-2026) Table 34. Global Oxycodone Drug Sales by Company (2021-2026) & (K Units) Table 35. Global Oxycodone Drug Sales Share by Company (2021-2026) Table 36. Global Oxycodone Drug Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Oxycodone Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Oxycodone Drug Major Company Production Sites and Headquarters Table 39. Global Oxycodone Drug Company, Product Type & Application Table 40. Global Oxycodone Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Oxycodone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Oxycodone Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Oxycodone Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Oxycodone Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global Oxycodone Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global Oxycodone Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Oxycodone Drug Sales by Region (2027-2032) & (K Units) Table 50. Global Oxycodone Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global Oxycodone Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global Oxycodone Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Oxycodone Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 56. Global Oxycodone Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global Oxycodone Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global Oxycodone Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global Oxycodone Drug Price by Application (2021-2026) & (US$/Unit) Table 60. Global Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 61. Global Oxycodone Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global Oxycodone Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global Oxycodone Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global Oxycodone Drug Price by Application (2027-2032) & (US$/Unit) Table 65. North America Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 66. North America Oxycodone Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 68. Europe Oxycodone Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Oxycodone Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 72. Latin America Oxycodone Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Oxycodone Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Endone Company Information Table 76. Endone Business Overview Table 77. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Endone Oxycodone Drug Product Portfolio Table 79. Endone Recent Development Table 80. Endone Company Information Table 81. Endone Business Overview Table 82. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Endone Oxycodone Drug Product Portfolio Table 84. Endone Recent Development Table 85. Hikma Pharmaceuticals USA Company Information Table 86. Hikma Pharmaceuticals USA Business Overview Table 87. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 89. Hikma Pharmaceuticals USA Recent Development Table 90. Hikma Pharmaceuticals USA Company Information Table 91. Hikma Pharmaceuticals USA Business Overview Table 92. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 94. Hikma Pharmaceuticals USA Recent Development Table 95. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 96. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 97. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 99. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 100. OxyContin Company Information Table 101. OxyContin Business Overview Table 102. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. OxyContin Oxycodone Drug Product Portfolio Table 104. OxyContin Recent Development Table 105. OxyContin Company Information Table 106. OxyContin Business Overview Table 107. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. OxyContin Oxycodone Drug Product Portfolio Table 109. OxyContin Recent Development Table 110. Oxynorm Company Information Table 111. Oxynorm Business Overview Table 112. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Oxynorm Oxycodone Drug Product Portfolio Table 114. Oxynorm Recent Development Table 115. Oxynorm Company Information Table 116. Oxynorm Business Overview Table 117. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Oxynorm Oxycodone Drug Product Portfolio Table 119. Oxynorm Recent Development Table 120. Proladone Company Information Table 121. Proladone Business Overview Table 122. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Proladone Oxycodone Drug Product Portfolio Table 124. Proladone Recent Development Table 125. Proladone Company Information Table 126. Proladone Business Overview Table 127. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Proladone Oxycodone Drug Product Portfolio Table 129. Proladone Recent Development Table 130. Purdue Pharma L.P Company Information Table 131. Purdue Pharma L.P Business Overview Table 132. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 134. Purdue Pharma L.P Recent Development Table 135. Purdue Pharma L.P Company Information Table 136. Purdue Pharma L.P Business Overview Table 137. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 139. Purdue Pharma L.P Recent Development Table 140. Sanofi-Aventis S.A. Company Information Table 141. Sanofi-Aventis S.A. Business Overview Table 142. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 144. Sanofi-Aventis S.A. Recent Development Table 145. Sanofi-Aventis S.A. Company Information Table 146. Sanofi-Aventis S.A. Business Overview Table 147. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 149. Sanofi-Aventis S.A. Recent Development Table 150. Sun Pharmaceutical Industries Ltd. Company Information Table 151. Sun Pharmaceutical Industries Ltd. Business Overview Table 152. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 154. Sun Pharmaceutical Industries Ltd. Recent Development Table 155. Targin Company Information Table 156. Targin Business Overview Table 157. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Targin Oxycodone Drug Product Portfolio Table 159. Targin Recent Development Table 160. Targin Company Information Table 161. Targin Business Overview Table 162. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Targin Oxycodone Drug Product Portfolio Table 164. Targin Recent Development Table 165. Pfizer Company Information Table 166. Pfizer Business Overview Table 167. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Pfizer Oxycodone Drug Product Portfolio Table 169. Pfizer Recent Development Table 170. Pfizer Company Information Table 171. Pfizer Business Overview Table 172. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 173. Pfizer Oxycodone Drug Product Portfolio Table 174. Pfizer Recent Development Table 175. Sun Pharmaceutical Industries Ltd. Company Information Table 176. Sun Pharmaceutical Industries Ltd. Business Overview Table 177. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 178. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 179. Sun Pharmaceutical Industries Ltd. Recent Development Table 180. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 181. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 182. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 183. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 184. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 185. North America Oxycodone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 186. North America Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 187. North America Oxycodone Drug Sales Market Share by Country (2021-2026) Table 188. North America Oxycodone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 189. North America Oxycodone Drug Sales Market Share Forecast by Country (2027-2032) Table 190. North America Oxycodone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 191. North America Oxycodone Drug Market Size by Country (2021-2026) & (US$ Million) Table 192. North America Oxycodone Drug Market Share by Country (2021-2026) Table 193. North America Oxycodone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 194. North America Oxycodone Drug Market Share Forecast by Country (2027-2032) Table 195. Europe Oxycodone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 196. Europe Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 197. Europe Oxycodone Drug Sales Market Share by Country (2021-2026) Table 198. Europe Oxycodone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 199. Europe Oxycodone Drug Sales Market Share Forecast by Country (2027-2032) Table 200. Europe Oxycodone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 201. Europe Oxycodone Drug Market Size by Country (2021-2026) & (US$ Million) Table 202. Europe Oxycodone Drug Market Share by Country (2021-2026) Table 203. Europe Oxycodone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 204. Europe Oxycodone Drug Market Share Forecast by Country (2027-2032) Table 205. Asia-Pacific Oxycodone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 206. Asia-Pacific Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 207. Asia-Pacific Oxycodone Drug Sales Market Share by Country (2021-2026) Table 208. Asia-Pacific Oxycodone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 209. Asia-Pacific Oxycodone Drug Sales Market Share Forecast by Country (2027-2032) Table 210. Asia-Pacific Oxycodone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 211. Asia-Pacific Oxycodone Drug Market Size by Country (2021-2026) & (US$ Million) Table 212. Asia-Pacific Oxycodone Drug Market Share by Country (2021-2026) Table 213. Asia-Pacific Oxycodone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 214. Asia-Pacific Oxycodone Drug Market Share Forecast by Country (2027-2032) Table 215. Latin America Oxycodone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 216. Latin America Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 217. Latin America Oxycodone Drug Sales Market Share by Country (2021-2026) Table 218. Latin America Oxycodone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 219. Latin America Oxycodone Drug Sales Market Share Forecast by Country (2027-2032) Table 220. Latin America Oxycodone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 221. Latin America Oxycodone Drug Market Size by Country (2021-2026) & (US$ Million) Table 222. Latin America Oxycodone Drug Market Share by Country (2021-2026) Table 223. Latin America Oxycodone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 224. Latin America Oxycodone Drug Market Share Forecast by Country (2027-2032) Table 225. Middle East and Africa Oxycodone Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 226. Middle East and Africa Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 227. Middle East and Africa Oxycodone Drug Sales Market Share by Country (2021-2026) Table 228. Middle East and Africa Oxycodone Drug Sales Forecast by Country (2027-2032) & (K Units) Table 229. Middle East and Africa Oxycodone Drug Sales Market Share Forecast by Country (2027-2032) Table 230. Middle East and Africa Oxycodone Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 231. Middle East and Africa Oxycodone Drug Market Size by Country (2021-2026) & (US$ Million) Table 232. Middle East and Africa Oxycodone Drug Market Share by Country (2021-2026) Table 233. Middle East and Africa Oxycodone Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 234. Middle East and Africa Oxycodone Drug Market Share Forecast by Country (2027-2032) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Oxycodone Drug Distributors List Table 238. Oxycodone Drug Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Oxycodone Drug Image Figure 2. Global Oxycodone Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Drug Sales (2021-2032) & (K Units) Figure 5. Anesthesia Image Figure 6. Global Anesthesia Sales YoY Growth (2021-2032) & (K Units) Figure 7. Anesthesia Image Figure 8. Global Anesthesia Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Pain Management Image Figure 12. Global Pain Management Sales YoY Growth (2021-2032) & (K Units) Figure 13. Pain Management Image Figure 14. Global Pain Management Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Oxycodone Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Oxycodone Drug Market Share by Type 2025 VS 2032 Figure 19. North America Oxycodone Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America Oxycodone Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe Oxycodone Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe Oxycodone Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Oxycodone Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Oxycodone Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America Oxycodone Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Oxycodone Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Oxycodone Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Oxycodone Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Oxycodone Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Ambulatory Surgical Centers (ASCs) Image Figure 32. Global Ambulatory Surgical Centers (ASCs) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Ambulatory Surgical Centers (ASCs) Image Figure 34. Global Ambulatory Surgical Centers (ASCs) Sales YoY Growth (2021-2032) & (K Units) Figure 35. Hospitals & Clinics Image Figure 36. Global Hospitals & Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 37. Hospitals & Clinics Image Figure 38. Global Hospitals & Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Oxycodone Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Oxycodone Drug Market Share by Application 2025 VS 2032 Figure 41. North America Oxycodone Drug Sales Market Share in Volume by Application in 2025 Figure 42. North America Oxycodone Drug Sales Market Share in Value by Application in 2025 Figure 43. Europe Oxycodone Drug Sales Market Share in Volume by Application in 2025 Figure 44. Europe Oxycodone Drug Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Oxycodone Drug Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Oxycodone Drug Sales Market Share in Value by Application in 2025 Figure 47. Latin America Oxycodone Drug Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Oxycodone Drug Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Oxycodone Drug Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Oxycodone Drug Sales Market Share in Value by Application in 2025 Figure 51. North America Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Oxycodone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Oxycodone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Oxycodone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Oxycodone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Oxycodone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Oxycodone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Oxycodone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Oxycodone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Oxycodone Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Oxycodone Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Oxycodone Drug Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Oxycodone Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthesia
  • Anesthesia
  • Others
  • Pain Management
  • Pain Management
  • Others
Applications
  • Ambulatory Surgical Centers (ASCs)
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals & Clinics
  • Hospitals & Clinics
Companies covered
  • Endone
  • Endone
  • Hikma Pharmaceuticals USA
  • Hikma Pharmaceuticals USA
  • Janssen Pharmaceuticals(Johnson & Johnson)
  • OxyContin
  • OxyContin
  • Oxynorm
  • Oxynorm
  • Proladone
  • Proladone
  • Purdue Pharma L.P
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Targin
  • Targin
  • Pfizer
  • Pfizer
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals(Johnson & Johnson)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oxycodone Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oxycodone Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oxycodone Drug Market by Type
  6. 1.3.1 Anesthesia
  7. 1.3.2 Anesthesia
  8. 1.3.3 Others
  9. 1.3.4 Pain Management
  10. 1.3.5 Pain Management
  11. 1.3.6 Others
  12. 1.4 Global Oxycodone Drug Market Size by Type
  13. 1.4.1 Global Oxycodone Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Oxycodone Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Oxycodone Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Oxycodone Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Oxycodone Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Oxycodone Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Oxycodone Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Oxycodone Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oxycodone Drug Industry Trends
  2. 2.2 Oxycodone Drug Industry Drivers
  3. 2.3 Oxycodone Drug Industry Opportunities and Challenges
  4. 2.4 Oxycodone Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oxycodone Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Oxycodone Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Oxycodone Drug Price (2021-2026)
  4. 3.4 Global Oxycodone Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oxycodone Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Oxycodone Drug Company, Product Type & Application
  7. 3.7 Global Oxycodone Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oxycodone Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oxycodone Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oxycodone Drug Tier 1, Tier 2, and Tier 3
4 Oxycodone Drug Regional Status and Outlook
  1. 4.1 Global Oxycodone Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oxycodone Drug Historic Market Size by Region
  3. 4.2.1 Global Oxycodone Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oxycodone Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oxycodone Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oxycodone Drug Forecasted Market Size by Region
  7. 4.3.1 Global Oxycodone Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oxycodone Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oxycodone Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oxycodone Drug by Application
  1. 5.1 Oxycodone Drug Market by Application
  2. 5.1.1 Ambulatory Surgical Centers (ASCs)
  3. 5.1.2 Ambulatory Surgical Centers (ASCs)
  4. 5.1.3 Hospitals & Clinics
  5. 5.1.4 Hospitals & Clinics
  6. 5.2 Global Oxycodone Drug Market Size by Application
  7. 5.2.1 Global Oxycodone Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Oxycodone Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Oxycodone Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Oxycodone Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Oxycodone Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Oxycodone Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Oxycodone Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Oxycodone Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Endone
  2. 6.1.1 Endone Company Information
  3. 6.1.2 Endone Business Overview
  4. 6.1.3 Endone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Endone Oxycodone Drug Product Portfolio
  6. 6.1.5 Endone Recent Developments
  7. 6.2 Endone
  8. 6.2.1 Endone Company Information
  9. 6.2.2 Endone Business Overview
  10. 6.2.3 Endone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Endone Oxycodone Drug Product Portfolio
  12. 6.2.5 Endone Recent Developments
  13. 6.3 Hikma Pharmaceuticals USA
  14. 6.3.1 Hikma Pharmaceuticals USA Company Information
  15. 6.3.2 Hikma Pharmaceuticals USA Business Overview
  16. 6.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  18. 6.3.5 Hikma Pharmaceuticals USA Recent Developments
  19. 6.4 Hikma Pharmaceuticals USA
  20. 6.4.1 Hikma Pharmaceuticals USA Company Information
  21. 6.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 6.4.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  24. 6.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 6.5 Janssen Pharmaceuticals(Johnson & Johnson)
  26. 6.5.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  27. 6.5.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  28. 6.5.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  30. 6.5.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
  31. 6.6 OxyContin
  32. 6.6.1 OxyContin Company Information
  33. 6.6.2 OxyContin Business Overview
  34. 6.6.3 OxyContin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 OxyContin Oxycodone Drug Product Portfolio
  36. 6.6.5 OxyContin Recent Developments
  37. 6.7 OxyContin
  38. 6.7.1 OxyContin Company Information
  39. 6.7.2 OxyContin Business Overview
  40. 6.7.3 OxyContin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 OxyContin Oxycodone Drug Product Portfolio
  42. 6.7.5 OxyContin Recent Developments
  43. 6.8 Oxynorm
  44. 6.8.1 Oxynorm Company Information
  45. 6.8.2 Oxynorm Business Overview
  46. 6.8.3 Oxynorm Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Oxynorm Oxycodone Drug Product Portfolio
  48. 6.8.5 Oxynorm Recent Developments
  49. 6.9 Oxynorm
  50. 6.9.1 Oxynorm Company Information
  51. 6.9.2 Oxynorm Business Overview
  52. 6.9.3 Oxynorm Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Oxynorm Oxycodone Drug Product Portfolio
  54. 6.9.5 Oxynorm Recent Developments
  55. 6.10 Proladone
  56. 6.10.1 Proladone Company Information
  57. 6.10.2 Proladone Business Overview
  58. 6.10.3 Proladone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Proladone Oxycodone Drug Product Portfolio
  60. 6.10.5 Proladone Recent Developments
  61. 6.11 Proladone
  62. 6.11.1 Proladone Company Information
  63. 6.11.2 Proladone Business Overview
  64. 6.11.3 Proladone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Proladone Oxycodone Drug Product Portfolio
  66. 6.11.5 Proladone Recent Developments
  67. 6.12 Purdue Pharma L.P
  68. 6.12.1 Purdue Pharma L.P Company Information
  69. 6.12.2 Purdue Pharma L.P Business Overview
  70. 6.12.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  72. 6.12.5 Purdue Pharma L.P Recent Developments
  73. 6.13 Purdue Pharma L.P
  74. 6.13.1 Purdue Pharma L.P Company Information
  75. 6.13.2 Purdue Pharma L.P Business Overview
  76. 6.13.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  78. 6.13.5 Purdue Pharma L.P Recent Developments
  79. 6.14 Sanofi-Aventis S.A.
  80. 6.14.1 Sanofi-Aventis S.A. Company Information
  81. 6.14.2 Sanofi-Aventis S.A. Business Overview
  82. 6.14.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  84. 6.14.5 Sanofi-Aventis S.A. Recent Developments
  85. 6.15 Sanofi-Aventis S.A.
  86. 6.15.1 Sanofi-Aventis S.A. Company Information
  87. 6.15.2 Sanofi-Aventis S.A. Business Overview
  88. 6.15.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  90. 6.15.5 Sanofi-Aventis S.A. Recent Developments
  91. 6.16 Sun Pharmaceutical Industries Ltd.
  92. 6.16.1 Sun Pharmaceutical Industries Ltd. Company Information
  93. 6.16.2 Sun Pharmaceutical Industries Ltd. Business Overview
  94. 6.16.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  96. 6.16.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  97. 6.17 Targin
  98. 6.17.1 Targin Company Information
  99. 6.17.2 Targin Business Overview
  100. 6.17.3 Targin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Targin Oxycodone Drug Product Portfolio
  102. 6.17.5 Targin Recent Developments
  103. 6.18 Targin
  104. 6.18.1 Targin Company Information
  105. 6.18.2 Targin Business Overview
  106. 6.18.3 Targin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Targin Oxycodone Drug Product Portfolio
  108. 6.18.5 Targin Recent Developments
  109. 6.19 Pfizer
  110. 6.19.1 Pfizer Company Information
  111. 6.19.2 Pfizer Business Overview
  112. 6.19.3 Pfizer Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Pfizer Oxycodone Drug Product Portfolio
  114. 6.19.5 Pfizer Recent Developments
  115. 6.20 Pfizer
  116. 6.20.1 Pfizer Company Information
  117. 6.20.2 Pfizer Business Overview
  118. 6.20.3 Pfizer Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Pfizer Oxycodone Drug Product Portfolio
  120. 6.20.5 Pfizer Recent Developments
  121. 6.21 Sun Pharmaceutical Industries Ltd.
  122. 6.21.1 Sun Pharmaceutical Industries Ltd. Company Information
  123. 6.21.2 Sun Pharmaceutical Industries Ltd. Business Overview
  124. 6.21.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  126. 6.21.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  127. 6.22 Janssen Pharmaceuticals(Johnson & Johnson)
  128. 6.22.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  129. 6.22.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  130. 6.22.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  132. 6.22.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
7 North America by Country
  1. 7.1 North America Oxycodone Drug Sales by Country
  2. 7.1.1 North America Oxycodone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oxycodone Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Oxycodone Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oxycodone Drug Market Size by Country
  6. 7.2.1 North America Oxycodone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oxycodone Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Oxycodone Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oxycodone Drug Sales by Country
  2. 8.1.1 Europe Oxycodone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oxycodone Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Oxycodone Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oxycodone Drug Market Size by Country
  6. 8.2.1 Europe Oxycodone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oxycodone Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oxycodone Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oxycodone Drug Sales by Country
  2. 9.1.1 Asia-Pacific Oxycodone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oxycodone Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oxycodone Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oxycodone Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Oxycodone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oxycodone Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oxycodone Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oxycodone Drug Sales by Country
  2. 10.1.1 South America Oxycodone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oxycodone Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Oxycodone Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oxycodone Drug Market Size by Country
  6. 10.2.1 South America Oxycodone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oxycodone Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Oxycodone Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oxycodone Drug Sales by Country
  2. 11.1.1 Middle East and Africa Oxycodone Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oxycodone Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oxycodone Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oxycodone Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Oxycodone Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oxycodone Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oxycodone Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oxycodone Drug Value Chain Analysis
  2. 12.1.1 Oxycodone Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oxycodone Drug Production Mode & Process
  7. 12.2 Oxycodone Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oxycodone Drug Distributors
  10. 12.2.3 Oxycodone Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst